Skip to content

Dry eye disease and oral Zinc supplement

The efficacy of oral Zinc supplement in young adult patients of dry eye disease associated with acne vulgaris- A Randomized controlled study - nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090848
Enrollment
60
Registered
2025-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Oral zinc supplement with lubricating drop: Oral zinc [50mg] twice daily for three months along with lubricating drop for dry eye disease Control Intervention1: Only Lubricating drop: P

Sponsors

The Investigator
Lead Sponsor
AIIMS Deoghar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All young adult patients [18 years to 30 years], presented with dry eye disease and also having concurrent Acne vulgaris and providing written consent for voluntary participation would be recruited for this study.

Exclusion criteria

Exclusion criteria: subjects with any known systemic illnesses like diabetes mellitus, thyroid disorders and auto-immune disorders. Subjects with history of smoking, alcohol consumption, or any other drugs like isotretonion, anti-histaminic, anti-cancer and beta-blockers would be excluded. Subjects with Computer work or mobile use of more than four hours in a day would also be excluded from the study.

Design outcomes

Primary

MeasureTime frame
To compare the clinical efficacy of oral Zinc supplement with the conventional treatment in young adult patients of dry eye disease associated with acne vulgaris.Timepoint: Two years

Secondary

MeasureTime frame
Secondary Objectives To compare the treatment response in terms of duration of treatment To compare the treatment response in terms of fastest clinical response.Timepoint: two years

Countries

India

Contacts

Public ContactSujit Das

AIIMS Deoghar

imdrsujitdas@gmail.com8527583337

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026